Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials. more
| Time Frame | SBIO | S&P500 |
|---|---|---|
| 1-Week Return | 5.9% | -0.58% |
| 1-Month Return | 6.93% | -3.58% |
| 3-Month Return | -14.21% | -2.98% |
| 6-Month Return | 4.18% | 1.47% |
| 1-Year Return | 29.57% | 10.06% |
| 3-Year Return | 141.83% | 70.31% |
| 5-Year Return | 23.96% | 61.76% |
| 10-Year Return | 128.58% | 246.24% |
| Time Frame | SBIO | S&P500 |
|---|---|---|
| 1-Week Return | 1,886.76% | -26.16% |
| 1-Month Return | 125.97% | -35.82% |
| 3-Month Return | -46.29% | -11.55% |
| 6-Month Return | 8.66% | 3.00% |
| 1-Year Return | 29.57% | 10.06% |
| 3-Year Return | 34.23% | 19.42% |
| 5-Year Return | 4.39% | 10.10% |
| 10-Year Return | 8.62% | 13.22% |
| Stock name | Ticker | Weight |
|---|---|---|
Oruka Therapeutics Inc.
|
ORKA |
4.46%
|
CG oncology Inc.
|
CGON |
4.4%
|
VeraDermics Inc.
|
MANE |
3.8%
|
Edgewise Therapeutics Inc.
|
EWTX |
3.2%
|
Dianthus Therapeutics Inc.
|
DNTH |
3.15%
|
Travere Therapeutics Inc.
|
TVTX |
3.05%
|
Definium Therapeutics Inc.
|
DFTX |
2.92%
|
Relay Therapeutics Inc.
|
RLAY |
2.67%
|
Xenon Pharmaceuticals Inc.
|
XENE |
2.48%
|
Amylyx Pharmaceuticals Inc.
|
AMLX |
2.43%
|
ACADIA Pharmaceuticals Inc.
|
ACAD |
2.39%
|
Dyne Therapeutics Inc.
|
DYN |
2.21%
|
Viridian Therapeutics Inc.
|
VRDN |
2.11%
|
Denali Therapeutics Inc.
|
DNLI |
2.1%
|
Disc Medicine Inc.
|
IRON |
1.98%
|
Ideaya Biosciences Inc.
|
IDYA |
1.97%
|
Tarsus Pharmaceuticals Inc.
|
TARS |
1.97%
|
Zai Lab Ltd.
|
ZLAB |
1.88%
|
Vericel Corp.
|
VCEL |
1.83%
|
Xencor Inc.
|
XNCR |
1.74%
|
Palvella Therapeutics Inc.
|
PVLA |
1.66%
|
MBX Biosciences Inc.
|
MBX |
1.62%
|
Celldex Therapeutics Inc.
|
CLDX |
1.54%
|
Newamsterdam Pharma Co. NV
|
NAMS |
1.48%
|
Lakefront Biotherapeutics NV
|
LKFT |
1.46%
|
Vera Therapeutics Inc.
|
VERA |
1.41%
|
Immunome Inc.
|
IMNM |
1.39%
|
BioCryst Pharmaceuticals Inc.
|
BCRX |
1.29%
|
Maze Therapeutics Inc.
|
MAZE |
1.24%
|
Sarepta Therapeutics Inc.
|
SRPT |
1.23%
|
Zenas Biopharma Inc.
|
ZBIO |
1.21%
|
Agios Pharmaceuticals Inc.
|
AGIO |
1.15%
|
Stoke Therapeutics Inc.
|
STOK |
1.12%
|
SELLAS Life Sciences Group Inc.
|
SLS |
1.11%
|
Kailera Therapeutics Inc.
|
KLRA |
1.1%
|
Generate Biomedicines Inc.
|
GENB |
1.1%
|
Immunocore Holdings PLC
|
IMCR |
1.05%
|
Nuvation Bio Inc.
|
NUVB |
0.96%
|
Structure Therapeutics Inc.
|
GPCR |
0.95%
|
Taysha Gene Therapies Inc.
|
TSHA |
0.92%
|
Mineralys Therapeutics Inc.
|
MLYS |
0.89%
|
LB Pharmaceuticals Inc.
|
LBRX |
0.89%
|
Nektar Therapeutics
|
NKTR |
0.83%
|
Tyra Biosciences Inc.
|
TYRA |
0.83%
|
MannKind Corp.
|
MNKD |
0.82%
|
SpyGlass Pharma Inc.
|
SGP |
0.81%
|
Compass Pathways PLC
|
CMPS |
0.78%
|
Vor BioPharma Inc.
|
VOR |
0.77%
|
Rapport Therapeutics Inc.
|
RAPP |
0.77%
|
Seaport Therapeutics Inc.
|
SPTX |
0.75%
|
Alto Neuroscience Inc.
|
ANRO |
0.65%
|
Immatics NV
|
IMTX |
0.62%
|
Corvus Pharmaceuticals Inc.
|
CRVS |
0.58%
|
MeiraGTx Holdings PLC
|
MGTX |
0.57%
|
Rigel Pharmaceuticals Inc.
|
RIGL |
0.48%
|
Solid Biosciences Inc.
|
SLDB |
0.46%
|
4D Molecular Therapeutics Inc.
|
FDMT |
0.44%
|
ArriVent Biopharma Inc.
|
AVBP |
0.44%
|
Candel Therapeutics Inc.
|
CADL |
0.44%
|
Wave Life Sciences Inc.
|
WVE |
0.43%
|
Fulgent Genetics Inc.
|
FLGT |
0.42%
|
Kura Oncology Inc.
|
KURA |
0.42%
|
Olema Pharmaceuticals Inc.
|
OLMA |
0.42%
|
Design Therapeutics Inc.
|
DSGN |
0.42%
|
Geron Corp.
|
GERN |
0.42%
|
Climb Bio Inc.
|
CLYM |
0.39%
|
Aclaris Therapeutics Inc.
|
ACRS |
0.38%
|
Bicara Therapeutics Inc.
|
BCAX |
0.38%
|
Delcath Systems Inc.
|
DCTH |
0.34%
|
Neurogene Inc.
|
NGNE |
0.33%
|
Oculis Holding AG
|
OCS |
0.3%
|
Relmada Therapeutics Inc.
|
RLMD |
0.27%
|
Tectonic Therapeutic Inc.
|
TECX |
0.26%
|
Altimmune Inc.
|
ALT |
0.26%
|
Zura Bio Ltd.
|
ZURA |
0.25%
|
C4 Therapeutics Inc.
|
CCCC |
0.25%
|
AgomAb Therapeutics NV
|
AGMB |
0.24%
|
Rezolute Inc.
|
RZLT |
0.24%
|
Allogene Therapeutics Inc.
|
ALLO |
0.23%
|
Enanta Pharmaceuticals Inc.
|
ENTA |
0.21%
|
Eikon Therapeutics Inc.
|
EIKN |
0.21%
|
X4 Pharmaceuticals Inc.
|
XFOR |
0.2%
|
Contineum Therapeutics Inc.
|
CTNM |
0.2%
|
Arcturus Therapeutics Holdings Inc.
|
ARCT |
0.19%
|
Fulcrum Therapeutics Inc.
|
FULC |
0.18%
|
SAB Biotherapeutics Inc.
|
SABS |
0.18%
|
Evommune Inc.
|
EVMN |
0.16%
|
Immuneering Corp.
|
IMRX |
0.15%
|
Inhibikase Therapeutics Inc.
|
IKT |
0.14%
|
Bicycle Therapeutics PLC
|
BCYC |
0.12%
|
Upstream Bio Inc.
|
UPB |
0.11%
|
MacroGenics Inc.
|
MGNX |
0.1%
|
Sionna Therapeutics Inc.
|
SION |
0.1%
|
Compass Therapeutics Inc.
|
CMPX |
0.09%
|
Protara Therapeutics Inc.
|
TARA |
0.09%
|
Akebia Therapeutics Inc.
|
AKBA |
0.07%
|
Anavex Life Sciences Corp.
|
AVXL |
0.07%
|
Immunic Inc.
|
IMUX |
0.07%
|
NovaBridge Biosciences
|
NBP |
0.07%
|
Tenax Therapeutics Inc.
|
TENX |
0.04%
|
Cash Equivalent
|
Cash.Equivalent |
0.01%
|
Novo Nordisk A/S
|
Novo.Nordisk.A.S |
0%
|
AstraZeneca PLC
|
AstraZeneca.PLC |
0%
|
Chinook Therapeutics Inc.
|
Chinook.Therapeutics.Inc. |
0%
|
| Sector | Weight |
|---|---|
|
Health care
|
101.04% |
ALPS Medical Breakthroughs ETF (SBIO) share price today is $58.229.
Yes, Indians can buy shares of ALPS Medical Breakthroughs ETF (SBIO) on Vested. To buy SBIO from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of ALPS Medical Breakthroughs ETF (SBIO) on Vested. You can start investing in ALPS Medical Breakthroughs ETF (SBIO) with a minimum investment of $1.
The 52-week high price of ALPS Medical Breakthroughs ETF (SBIO) is $70.85. The 52-week low price of ALPS Medical Breakthroughs ETF (SBIO) is $44.8.
The stock symbol (or ticker) of ALPS Medical Breakthroughs ETF is SBIO.
Yes, you can setup SIP in ALPS Medical Breakthroughs ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of SBIO on the Vested app.
The expense ratio of ALPS Medical Breakthroughs ETF (SBIO) is 0.49%.
Link copied